SOTIO to Present at the LifeSci Partners Summer Symposium
PRAGUE, Czech Republic, July 30, 2020 (GLOBE NEWSWIRE) -- SOTIO, a clinical stage immuno-oncology company owned by PPF Group, today announced that Radek Špíšek, chief executive officer of SOTIO, will be presenting a corporate overview at the Private Healthcare Company Virtual Summer Symposium, hosted by LifeSci Partners on August 4 and 5, 2020. Please click the following link to register: https://lifesci.events/SummerSymposium
|Date:||August 5, 2020|
|Time:||10:00 a.m. EDT|
|Company contact:||Media contact:|
|Richard Kapsa||Kirsten Frazer, Ph.D.|
|Head of Communication||LifeSci Communications|
|T: (+420) 224 174 448||T: +1 646-863-0222|
|M: (+420) 603 280 firstname.lastname@example.org|
SOTIO is shaping the future of cancer immunotherapies by translating compelling science into patient benefit. SOTIO’s robust clinical pipeline includes a differentiated superagonist of the attractive immuno-oncology target IL-15, a platform to streamline personalized active immune cell therapies and a new generation of potent and stable antibody-drug conjugates (ADCs). SOTIO is a member of the PPF Group. For more information, please visit the company’s website at www.sotio.com.
SOTIO is a registered trademark of SOTIO a.s. in selected countries.
Upcoming Life Sciences Events
- January 2021
- BioSeed Digital 2021